Physical Activity and Quality of Life in Postmenopausal Women
Impact of a Physical Activity Program on Body Composition, Strength, and Quality of Life in Postmenopausal Women
1 other identifier
interventional
36
1 country
1
Brief Summary
The goal of this clinical trial is to investigate the effects of a combined aerobic and muscle-strengthening training program on body composition, physical fitness, and quality of life in overweight or obese postmenopausal women. The main question it aims to answer is: Does this training modality improve body composition, enhance physical fitness, and increase quality of life in this population ? Researchers will compare outcomes between an experimental group following the training protocol and a control group with no training intervention, in order to determine whether the program leads to measurable improvements in these parameters. Participants in the training group will engage in aerobic exercise at 50-70% of heart rate reserve (HRR) and strength training at 60-70% of one-repetition maximum (1-RM), three times per week for 8 months. Participants in the control group will not engage in any structured physical training and will be asked to maintain their usual daily routines.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable quality-of-life
Started Oct 2024
Shorter than P25 for not_applicable quality-of-life
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2025
CompletedFirst Submitted
Initial submission to the registry
July 9, 2025
CompletedFirst Posted
Study publicly available on registry
July 20, 2025
CompletedJuly 20, 2025
May 1, 2025
8 months
July 9, 2025
July 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (9)
Body weight
Body weight (kg) was recorded with participants barefoot and wearing light clothing, using the InBody 270 bioelectrical impedance device (InBody, Cerritos, CA, USA).
Baseline (Day 0) and after 8 months of intervention.
Body fat
Body fat (%) was recorded using the InBody 270 bioelectrical impedance device (InBody, Cerritos, CA, USA).
Baseline (Day 0) and after 8 months of intervention.
Body mass index
Body mass index (kg/m²) was calculated as weight (kg) divided by height squared (m²).
Baseline (Day 0) and after 8 months of intervention.
Lean mass
Lean mass (%) was recorded with participants barefoot and wearing light clothing, using the InBody 270 bioelectrical impedance device (InBody, Cerritos, CA, USA).
Baseline (Day 0) and after 8 months of intervention.
Basal metabolic rate
Basal metabolic rate (kcal/day) was assessed using the InBody 270 bioelectrical impedance device (InBody, Cerritos, CA, USA).
Baseline (Day 0) and after 8 months of intervention.
Aerobic Capacity
Aerobic capacity was assessed using the 6-minute walk test (6MWT), administered according to standardized procedures, with participants walking on a flat, straight course for six minutes.
Baseline (Day 0) and after 8 months of intervention.
Lower limb functional strength.
Lower limb functional strength was assessed using the 30-Second Chair Stand Test.
Baseline (Day 0) and after 8 months of intervention.
Agility and dynamic balance
Agility and dynamic balance were assessed using the 8-Foot Up and Go (8UG) test.
Baseline (Day 0) and after 8 months of intervention.
Quality of life (SF-36 Questionnaire)
Quality of life was assessed using the Short Form Health Survey 36 (SF-36), a validated 36-item questionnaire measuring physical and mental health domains.
Baseline (Day 0) and after 8 months of intervention.
Study Arms (2)
Training group
EXPERIMENTALThe experimental group performed a combined training program consisting of aerobic training at 50-70% of heart rate reserve (HRR) and muscle-strengthening training at 60-70% of one-repetition maximum (1-RM), three times per week for eight months.
Control group
NO INTERVENTIONNo training intervention was intended for the control group.
Interventions
A combined training program including both aerobic and muscle-strengthening physical activities within the same session, conducted over a period of 8 months. Aerobic training is performed at an intensity of 50-70% of heart rate reserve (HRR), and strength training at 60-70% of one-repetition maximum (1-RM). The training is conducted three times per week.
Eligibility Criteria
You may qualify if:
- Age range (50-62 years).
- Postmenopausal women (absence of menstruation \> 12 months).
- Body mass index (BMI) ≥ 25 kg/m².
- Body weight remained constant (±2 kg) for the past 3 months.
- Stable dietary habits and physical activity for at least 3 months.
- Sedentary lifestyle (physical activity less than 1 hour per week).
You may not qualify if:
- Medical contraindications to physical activity.
- Metabolic, hormonal, orthopedic, or cardiovascular diseases.
- Current use of hormone replacement therapy or any prescribed medication.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Wissal Abassilead
Study Sites (1)
Department of Biological and Environmental Sciences and Technologies (DiSTeBA), University of Salento, Centro Ecotekne, Pal. B S.P. 6
Lecce, LE (Lecce), 73100, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Antonella MUSCELLA, Professor
Department of Biological and Environmental Science and Technologies (DiSTeBA), University of Salento, 73100 Lecce, Italy.
- PRINCIPAL INVESTIGATOR
Wissal Abassi, Dr
Research Unit "Sport Sciences, Health and Movement"(UR22JS01) High Institute of Sport and Physical Education of Kef, University of Jendouba, 7100 Kef, Tunisia.
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 9, 2025
First Posted
July 20, 2025
Study Start
October 1, 2024
Primary Completion
May 31, 2025
Study Completion
May 31, 2025
Last Updated
July 20, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share
For confidentiality reasons, all data from this study are available upon request.